Log in

NASDAQ:GENEGenetic Technologies Stock Price, Forecast & News

$2.04
0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.99
Now: $2.04
$2.15
50-Day Range
$1.60
MA: $2.07
$2.52
52-Week Range
$1.41
Now: $2.04
$5.36
Volume1.16 million shs
Average Volume1.21 million shs
Market Capitalization$17.38 million
P/E RatioN/A
Dividend YieldN/A
Beta2.58
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage the women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. The company has a research and service agreement with The University of Melbourne for the development and enhancement of the BREVAGenplus breast cancer risk assessment test, as well as a strategic alliance with Blockchain Global Limited. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.38 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GENE
CUSIPN/A
Phone011-61-3-8412-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20,000.00
Book Value$0.26 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$17.38 million
Next Earnings DateN/A
OptionableOptionable

Receive GENE News and Ratings via Email

Sign-up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter.

Genetic Technologies (NASDAQ:GENE) Frequently Asked Questions

How has Genetic Technologies' stock been impacted by COVID-19 (Coronavirus)?

Genetic Technologies' stock was trading at $2.36 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GENE stock has decreased by 13.6% and is now trading at $2.04. View which stocks have been most impacted by Coronavirus.

Has Genetic Technologies been receiving favorable news coverage?

Media headlines about GENE stock have been trending negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Genetic Technologies earned a coverage optimism score of -2.6 on InfoTrie's scale. They also assigned media coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutGenetic Technologies.

Who are some of Genetic Technologies' key competitors?

What other stocks do shareholders of Genetic Technologies own?

Who are Genetic Technologies' key executives?

Genetic Technologies' management team includes the following people:
  • Dr. Paul Alexander Kasian Ph.D., Exec. Chairman & CEO (Age 62)
  • Dr. Jerzy Muchnicki, Exec. Director & Bus. Devel. Director
  • Mr. Paul Keith Mathieson Viney B. Bus, FCPA, FGIA, FCI, COO, CFO & Company Sec.

What is Genetic Technologies' stock symbol?

Genetic Technologies trades on the NASDAQ under the ticker symbol "GENE."

How do I buy shares of Genetic Technologies?

Shares of GENE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genetic Technologies' stock price today?

One share of GENE stock can currently be purchased for approximately $2.04.

How big of a company is Genetic Technologies?

Genetic Technologies has a market capitalization of $17.38 million and generates $20,000.00 in revenue each year.

What is Genetic Technologies' official website?

The official website for Genetic Technologies is www.gtgcorporate.com.

How can I contact Genetic Technologies?

Genetic Technologies' mailing address is 60-66 HANOVER STREET, FITZROY C3, 3065. The biotechnology company can be reached via phone at 011-61-3-8412-7000 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.